BRPI0604024A - cancer prevention foods and jasmonate based pharmaceutical compositions - Google Patents
cancer prevention foods and jasmonate based pharmaceutical compositionsInfo
- Publication number
- BRPI0604024A BRPI0604024A BRPI0604024A BRPI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- jasmonate
- foods
- cancer prevention
- based pharmaceutical
- Prior art date
Links
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
ALIMENTOS PARA A PREVENçãO DO CáNCER E COMPOSIçõES FARMACêUTICAS à BASE DO JASMONATO. A presente patente de invenção apresenta combinações de jasmonatos como uma droga potente, na produção e/ou acúmulo de substâncias preventivas do câncer em alimentos de qualquer espécie e composições farmacêuticas com ação cicatrizante, bacteriostática, cosmética, analgésica. entre outras. Os alimentos e as composições farmacêuticas apresentadas não são tóxicos para células sadias por possuírem como ingrediente ativo formas de jasmonato, hormónio anti-estresse de plantas.CANCER PREVENTION FOOD AND JASMONATE BASED PHARMACEUTICAL COMPOSITIONS. The present patent discloses combinations of jasmonates as a potent drug in the production and / or accumulation of cancer preventive substances in foods of any kind and pharmaceutical compositions with healing, bacteriostatic, cosmetic, analgesic action. among others. The foods and pharmaceutical compositions presented are not toxic to healthy cells because they have as active ingredient forms of jasmonate, anti-stress hormone of plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0604024 BRPI0604024A (en) | 2006-09-01 | 2006-09-01 | cancer prevention foods and jasmonate based pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0604024 BRPI0604024A (en) | 2006-09-01 | 2006-09-01 | cancer prevention foods and jasmonate based pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0604024A true BRPI0604024A (en) | 2008-04-22 |
Family
ID=39309848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0604024 BRPI0604024A (en) | 2006-09-01 | 2006-09-01 | cancer prevention foods and jasmonate based pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0604024A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010006392A2 (en) * | 2008-07-15 | 2010-01-21 | Fehr Pereira Lopes Jose E | Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es |
US8883220B2 (en) | 2011-09-16 | 2014-11-11 | Nanocare Technologies, Inc. | Compositions of jasmonate compounds |
US10314918B2 (en) | 2014-12-31 | 2019-06-11 | Nanocare Technologies, Inc. | Jasmonate derivatives and compositions thereof |
-
2006
- 2006-09-01 BR BRPI0604024 patent/BRPI0604024A/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010006392A2 (en) * | 2008-07-15 | 2010-01-21 | Fehr Pereira Lopes Jose E | Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es |
WO2010006392A3 (en) * | 2008-07-15 | 2010-03-18 | Fehr Pereira Lopes Jose E | Pharmaceutical composition comprising jasmonates |
US8883220B2 (en) | 2011-09-16 | 2014-11-11 | Nanocare Technologies, Inc. | Compositions of jasmonate compounds |
US9592305B2 (en) | 2011-09-16 | 2017-03-14 | Nanocare Technologies, Inc. | Compositions of jasmonate compounds and methods of use |
US10328155B2 (en) | 2011-09-16 | 2019-06-25 | Nanocare Technologies, Inc. | Compositions of jasmonate compounds and methods of use |
US10314918B2 (en) | 2014-12-31 | 2019-06-11 | Nanocare Technologies, Inc. | Jasmonate derivatives and compositions thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014011841A2 (en) | hydrophobic drug delivery material, method for producing the same and methods for delivering a drug delivery composition | |
BR112012005044A2 (en) | compositions comprising tramadol and celecoxib in the treatment of pain. | |
WO2012142511A3 (en) | Orthomolecular compositions and their use in stabilizing the extracellular matrix | |
EA201401028A1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY | |
CL2010001260A1 (en) | Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis. | |
UY32989A (en) | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COPOSITIONS | |
CO5640037A2 (en) | DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER | |
GT200600260A (en) | BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME | |
SV2010003674A (en) | DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE | |
MY167691A (en) | A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid | |
BR112014005358A2 (en) | pain relief composition comprising a selective trpv1 agonist, and its manufacture and use | |
CL2007001724A1 (en) | USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1 | |
BR112012016330B8 (en) | ampk thieno[2,3-b]pyridinedione activators and pharmaceutical composition comprising the same | |
BRPI0819152B8 (en) | topical pharmaceutical composition | |
CL2007003480A1 (en) | COMPOUNDS DERIVED FROM TIAZOLO [5,4-C] PIRIDIN-4-ONA REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OR PREVENTION OF OBESITY-RELATED DISEASES, AS FOOD DISORDERS, DIAB | |
UY30215A1 (en) | CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
CL2007002875A1 (en) | Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms. | |
SV2009002953A (en) | NEW ACICLIC FUROPIRIMIDINE DERIVATIVES SUBSTITUTED AND ITS USE | |
CR9911A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE COMBINATIONS OF ANALGESIC AND ANTI-CONVULSIVANTS FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN | |
NI201300045A (en) | APOPTOSIS INHIBITORS AND USES OF THEM. | |
DE602006009259D1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL | |
IL205290A (en) | Variant of human neurturin protein, or a biologically active fragment thereof, pharmaceutical compositions comprising it and use thereof in the manufacture of medicaments for therapy | |
SV2006002384A (en) | PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE | |
MA32635B1 (en) | Pharmaceutical product and associated treatment | |
BRPI0604024A (en) | cancer prevention foods and jasmonate based pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |